Preferred Supramolecular Organization and Dimer Interfaces of Opioid Receptors from Simulated Self-Association

Substantial evidence in support of the formation of opioid receptor (OR) di-/oligomers suggests previously unknown mechanisms used by these proteins to exert their biological functions. In an attempt to guide experimental assessment of the identity of the minimal signaling unit for ORs, we conducted extensive coarse-grained (CG) molecular dynamics (MD) simulations of different combinations of the three major OR subtypes, i.e., μ-OR, δ-OR, and κ-OR, in an explicit lipid bilayer. Specifically, we ran multiple, independent MD simulations of each homomeric μ-OR/μ-OR, δ-OR/δ-OR, and κ-OR/κ-OR complex, as well as two of the most studied heteromeric complexes, i.e., δ-OR/μ-OR and δ-OR/κ-OR, to derive the preferred supramolecular organization and dimer interfaces of ORs in a cell membrane model. These simulations yielded over 250 microseconds of accumulated data, which correspond to approximately 1 millisecond of effective simulated dynamics according to established scaling factors of the CG model we employed. Analysis of these data indicates similar preferred supramolecular organization and dimer interfaces of ORs across the different receptor subtypes, but also important differences in the kinetics of receptor association at specific dimer interfaces. We also investigated the kinetic properties of interfacial lipids, and explored their possible role in modulating the rate of receptor association and in promoting the formation of filiform aggregates, thus supporting a distinctive role of the membrane in OR oligomerization and, possibly, signaling.

[1]  Aashish Manglik,et al.  Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.

[2]  Physikalische Gesellschaft Position-dependent diffusion coefficients and free energies from Bayesian analysis of equilibrium and replica molecular dynamics simulations , 2005 .

[3]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[4]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[5]  R. Metzler,et al.  Anomalous and normal diffusion of proteins and lipids in crowded lipid membranes. , 2013, Faraday discussions.

[6]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[7]  David J. Daniels,et al.  A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. , 2004, Journal of medicinal chemistry.

[8]  Siewert J Marrink,et al.  Transmembrane helices can induce domain formation in crowded model membranes. , 2012, Biochimica et biophysica acta.

[9]  Bryan L. Roth,et al.  Molecular control of δ-opioid receptor signalling , 2014, Nature.

[10]  D. Tieleman,et al.  The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.

[11]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[12]  R. Stevens,et al.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.

[13]  L. Devi,et al.  Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity , 2013, Proceedings of the National Academy of Sciences.

[14]  Shaoqiu He,et al.  Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation , 2011, Neuron.

[15]  J. Pintar,et al.  Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands , 2010, Psychopharmacology.

[16]  Lakshmi A Devi,et al.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Filizola,et al.  Lessons from Free Energy Simulations of δ-Opioid Receptor Homodimers Involving the Fourth Transmembrane Helix† , 2010, Biochemistry.

[18]  George Khelashvili,et al.  Membrane Driven Spatial Organization of GPCRs , 2013, Scientific Reports.

[19]  Martin J. Lohse,et al.  G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives , 2014, Pharmacological Reviews.

[20]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[21]  Xavier Periole,et al.  Combining an Elastic Network With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular Recognition. , 2009, Journal of chemical theory and computation.

[22]  H. Kramers Brownian motion in a field of force and the diffusion model of chemical reactions , 1940 .

[23]  Jianyun Huang,et al.  Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.

[24]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[25]  R. Larson,et al.  The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.

[26]  Siewert J Marrink,et al.  Structural determinants of the supramolecular organization of G protein-coupled receptors in bilayers. , 2012, Journal of the American Chemical Society.

[27]  J. Whistler,et al.  Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers. , 2012, ACS medicinal chemistry letters.

[28]  Marta Filizola,et al.  Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors , 2014, PloS one.

[29]  Jamie Fong,et al.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[31]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[32]  Dynamical exchanges in facilitated models of supercooled liquids. , 2005, The Journal of chemical physics.

[33]  David Baker,et al.  Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.

[34]  Titiwat Sungkaworn,et al.  Single-molecule analysis of fluorescently labeled G-protein–coupled receptors reveals complexes with distinct dynamics and organization , 2012, Proceedings of the National Academy of Sciences.

[35]  C. Jarzynski Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.

[36]  J. Klafter,et al.  The random walk's guide to anomalous diffusion: a fractional dynamics approach , 2000 .

[37]  George Khelashvili,et al.  Quantitative modeling of membrane deformations by multihelical membrane proteins: application to G-protein coupled receptors. , 2011, Biophysical journal.

[38]  J. Mulder,et al.  Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration , 2010, Science Signaling.

[39]  H. Loh,et al.  Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling , 2012, BMC Cell Biology.

[40]  Vadim Cherezov,et al.  A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.

[41]  L. Devi,et al.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10 , 2014, British journal of pharmacology.

[42]  Peter M. Kasson,et al.  Dynamic heterogeneity controls diffusion and viscosity near biological interfaces , 2014, Nature Communications.

[43]  David J. Daniels,et al.  Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores. , 2007, European journal of pharmacology.

[44]  Andrew Thomas,et al.  The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.

[45]  Mark S. P. Sansom,et al.  Reduced Lateral Mobility of Lipids and Proteins in Crowded Membranes , 2013, PLoS Comput. Biol..

[46]  Marta Filizola,et al.  Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery? , 2010, Life sciences.

[47]  Lakshmi A. Devi,et al.  A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia , 2004 .

[48]  Veronika Kralj-Iglič,et al.  Interaction between two cylindrical inclusions in a symmetric lipid bilayer , 2003 .